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Abstract 
Transcripts of the human IFN a-receptor (IFNAR) gene, lackmg the transmembrane (TM) domam were found m human myeloma U266s cells, 
m addltlon to the transmembranal IFNAR cDNA Two different cDNAs encodmg such soluble IFNAR forms were Identified Form 1 has a deletion 
causmg a frameshlft toward the end of the extracellular (EC) domam predlctmg a tall of 7 ammo acids Form 2 has two m-frame deletions and 
conserves most of the mtracytoplasmatlc domam of IFNAR The transcripts for the two soluble forms are still found m U266R cells which have lost 
the transmembranal IFNAR transcnpt Human cells seem to have Independent mechanisms to synthesize soluble IFN receptors, which may act as 
competitors outslde the cells or carry IFN-medlated functions mslde the cell 
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1. Introduction 
Cytokmes, among which mterferons (IFNs), are cell 
secreted protems which typically act from the outside of 
cells through spectfic plasma membrane receptors As a 
common feature, these receptors have a ligand-binding 
extracellular (EC) domain, separated from an mtracyto- 
plasmattc (IC) domain by an internal sequence of hydro- 
phobtc ammo acids (aa), the transmembrane (TM) 
domain, which anchors the receptor m the cell outer 
membrane [I] In addition, forms of cytokme receptors 
lacking the TM and IC domains (soluble receptors) have 
been characterized (see [2] for review) Such forms may 
result from proteolytic cleavage between the EC and TM 
domains [3,4]. However, soluble receptors of several cy- 
tokmes were shown to be encoded by mRNAs arising 
from differenttal processing of the receptor gene tran- 
scripts. mdtcatmg that these forms are synthesized by the 
cells along with the transmembranal receptors [5,6] 
Cloning of the IFN &-Receptor (IFNAR) cDNA [7] 
revealed a transmembranal protein with a 21 ammo acid- 
long hydrophobic TM region, an N-terminal EC domam 
(436 aa) mvolved m hgand bmdmg [8,9] and a C-termmal 
IC domain (100 aa) Recently, Novtck et al. [S] reported 
the presence of soluble IFNAR molecules m body fluids. 
To investigate the existence of gene transcripts encoding 
soluble IFNAR forms, we analyzed RNA from human 
____ 
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myeloma U266 cells, by reverse transcription and polym- 
erase chain reaction (PCR) Besides the transmembranal 
IFNAR cDNA, we Identified two addttional mRNAs 
which encode different soluble IFNAR forms, one trun- 
cated after the EC domain, the other with m-phase dele- 
tions conserving both EC and IC domains 
2. Materials and methods 
2 I Cell cultures 
Human myeloma cells U266 (American Type Culture Collection, 
Rockvdle, MD), or U266’, were cultured m RPM1 1640 (Blolabs, 
Israel), supplemented with 10% heat-mactlvated fetal calf serum, at 
37°C m 5% CO? The U266R cells have been denved by long term 
culture m mcreasmg concentrations of human IFN-a, up to 2,000 
IU/ml, and these IFN-reslstant cells grow with the same doubhng time 
as the ongmal U266’ cells 
2 2 RNA ewtractron, cDNA preparatlon, primers and PCR 
Total cell RNA was prepared by the guamdme thlocyanate method 
[lo], and cDNA was synthesized with reverse transcnptase (Boehnnger, 
Mannhelm) usmg ohgonucleotlde pnmer 5, complementary to residues 
1,729-1,749 of the IFNAR cDNA sequence [7], and accordmg to pub- 
hshed protocols [I 1] The cDNA reactlons were diluted 1 5 m water, 
appropnate ohgonucleotlde pnmers were added and PCR amphfica- 
tlon was performed with Taq polymerase (Promega Blotec, Madison, 
WI), with 35 cycles of 1 mm at 92”C, 1 mm at 55°C and 1 mm at 72’C 
The followmg pnmers were used (added restnctlon sites m lower case 
and coordmates numbered as m IFNAR cDNA, ref [7]) Pnmer 1 
(sense 1,270-l ,290) 5’-gctcgaattCCACTGACTGTATATTGTGTG, 
Pnmer 2 (sense 1,342-1,361) 5’-AGTGACGCTGTATGTGAGAA, 
Pnmer 2a (sense 1.331-1,343) 5’-acgtgaattcGCAGTGTTTAG, 
Primer 2b (sense 1,320-1,336) 5’-gatcgaattcGCTGAATAAAAG- 
CAGTG, Pnmer 3 (antlsense 1,498-l ,5 15) 5’-ATCTATACTG- 
GAAGAAGG, Pnmer 4 (sense 1,522-1,542) S-TTCTCTGAACAGC- 
CATTGAAG, Pnmer 5 (antlsense 1,729-1,749) 5’-TACAAAG- 
TCCTGCTGTAGTTC, Primer 5a (antlsense 1,733-1,752) 5’-cgaag- 
0014-5793/94/$7 00 0 1994 Federation f European Blochemlcal Socletles All nghts reserved 
SSDI 0014-5793(93)El532-Q 
296 C Abramovlch et al IFEBS Letters 338 (1994) 295-300 
TRANSMEMBRANAL IFN RECEPTOR cDNA FORM 
1362---deleted---1518 
PRIMERS 1 2 34 5 
SOLUBLE FN RECEPTOR cDNA FORM 1 
PRIMERS 1 2 4 5 
Fig 1 (upper) Scheme of part of the transmembranal IFNAR cDNA [7] with end of EC domam (cross-hatched box), TM domain (black box) and 
IC domain (open box) PosItIon of some of the PCR pnmers shown by arrows (right pointed, sense, left-pointed, antisense) The deletion m soluble 
IFNAR cDNA form 1 1s indicated as deduced from sequence m Fig 3 (lower) Scheme of same region m form 1 Novel S domain of seven C-termmal 
ammo acids shown by open box 
gatccTCATACAAAGTCCTGCTGTA, Primer 6 (antlsense 1,601- 
1,619) S-ACTGTAGCAATTGTGCTTA 
2 3 Clonrng and sequencrng of PCR products 
For cloning, PCR products were synthesized with pnmers starting 
with tails containing EcoRI sites (sense primers 1, 2a, 2b) and BamHI 
sites (antisense pnmer Sa) The products were digested with EcoRI and 
BarnHI, separated on 2% agarose gels, purified and cloned m the 
BlueScnpt KS’ vector (Stratagene Clonmg Systems, LaJolla, CA) 
which had been cut by the same restriction enzymes Plasmlds with PCR 
DNA inserts were sequenced using the Sequenase Version 2 0 DNA 
sequencing kit (USB, Cleveland, OH) as described [12] Sequencing was 
done from the T3 pnmer of the BlueScript DNA and the complemen- 
tary strand from pnmer 6 (antisense 1,601-1.619) 
3. Results 
ment originates from a different transcrtpt. was indicated 
by the study of RNA from U266R cells, avariant isolated 
by resistance to growth mhtbition by IFN-a With prim- 
ers 2 and 5, U266R cDNA gave only the 260 bp PCR 
product, m the absence of the 420 bp product (Fig 2, 
lane 4) This result suggested that the 260 bp product 
corresponds to a separate deleted transcript produced by 
both S and R U266 cell types, the latter cells lackmg the 
full length IFNAR transcript. Several other pans of 
PCR P!4ODUCTS FROM IFN a-RECEPTOR cDNA 
IN U266’ and U266R CELLS 
U266 ’ U266 U266 
S/R SIRI 
3 1 Muhple IFNAR cDNAs from U266 cell RNA 
From RNA of human myeloma U266’ cells, smgle 
stranded cDNA was synthesized by priming with an ol- 
tgonucleotide (primer 5 m Fig 1) complementary to the 
end of the IFNAR cDNA coding region (residues 1,729- 
1,749) reported by Uze et al [7] The cDNA was sub- 
jected to PCR amphfication with three pan-s of sense and 
antisense primers, posmoned on the sequence of the 
transmembranal IFNAR cDNA, as Illustrated m the 
upper part of Fig. 1 The PCR DNA products were 
analyzed by agarose gel electrophorests and ethidmm 
bromide stammg (Fig 2) With primers 2 and 5 (span- 
nmg residues 1,342 to 1,749), two bands of amplified 
DNA were observed (Fig 2, lane 3) the longer one of 
about 420 bp, was m the range expected for the trans- 
membranal IFNAR cDNA, the second product being 
shorter and about 260 bp That this shorter DNA frag- 
420 bp 
260 bp 
Fig 2 Polymerase chain reactlon (PCR) products of cDNA from 
U266’ (lanes 1,3,5) and U266R (lanes 2,4,6) cellular RNA, with pnmers 
Indicated m Fig 1 Lanes 1,2 primers 2 and 3 Lanes 3,4 pnmers 2 and 
5 Lanes 5,6 pnmers 4 and 5 M, @Xl74 DNA HaeIII digest markers 
Ethldmm bromide stained agarose gel electrophoresls Approximated 
size of products shown by arrows 
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A 
TM 
Sol-l 
TM 
TM 
TM 
Sol-1 
TM 
Sol-1 
B 
TM 
TM 
DELETION IN SOLUBLE FORM-1 OF IF'NAR cDNA 
prxner Za 1350 exon IX I x 1380 
GC AGT GTT TTT AGT GAC GCT GTA TGT GAG AAA ACA AAA CCA GGA ART ACC 
GcAGl! OTT TTTAGTGAC GcTG?alwrGAGM 
1410 1440 
TCT AAA ATT TGG CTT ATA GTT GGA ATT TGT ATT GCA TTA TTT GCT CTC CCG TTT GTC ATT 
1470 1500 
TAT GCT GCG A?U GTC TTC TTG AGA TGC ATC AAT TAT GTC TTC TTT CCA TCA CTT AAA CCT 
exon x I XI 1530 Prlrne.r 4 1560 
TCT TCC AGT ATA GAT GAG TAT TTC TCT GAA CAG-CCA TTG AAG AAT CTT CTG CTT TCA ACT 
TAT l-lx TCT GM CJiG CCA TTGMGAAT CTT CTG CTT TCAACLCT 
1590 1620 
TCT GAG GAA CAA ATC GAA AAA TGT TTC ATA ATT GAA AAT ATA AC% ACA ATT GCT ACA GTA 
TCTDAGOAACBBATCOllABABTDTTn:ATAATTGBRABT*~ADC-*TTOCT-GTA 
(extracellular) exon IX I exon x I exon XI (Intracytoplasmatlc) 
t427 #431 15aa 121aa1 23aa I 77aa 
C E K T K P IG i TM i 
TGT GAG AAa aca aaa cca glga [ I g:, g:giTiT T,'C Tb Gk C:G Ch T,"G AiG 
I I 
1361 1519 
I I 
II 
Tel! GAGAATATT KT CTGAAC AGC CAT TGA 
CBNISLNSH' 
#427 
Fig 3 (A) Partial nucleotlde sequence of cloned PCR products made with primers 2a and 5 TM designates the sequence of the larger product of 
about 420 bp (slmllar to Fig 2, lane 3) ldentlcal to the transmembranal IFNAR cDNA Codons of the TM domain are doubly underhned, and exons 
boundaries [13] are mdlcated Sol-l designates the correspondmg sequence of the smaller product of about 260 bp (soluble IFNAR cDNA form 1, 
bold characters), interrupted by deletion (B) Translational frameshlft and predlcted C-termmus of soluble IFNAR form 1 (sol-l) compared to 
transmembranal IFNAR (TM) 
primers revealed that the deletion is around the TM 
region Thus, with primers 2 and 3 (spanning nucleotides 
1,342 to 1,515, Fig. l), U266R cDNA did not give any 
product, whereas the expected PCR product (173 bp) 
was clearly observed with U266’ cDNA (Fig 2, lanes 1 
and 2). With primers 4 and 5 (spanmng residues 1,522 
to 1,749) the same unique PCR product was seen for 
both cell types (Fig. 2, lanes 5 and 6) indicating no heter- 
ogeneity m this region Likewise, PCR reactions with 
other primer pairs (sense 83-102 and antisense 553-572; 
TRANSMEMBRANU FN RECEPTOR cDNA FORM 
1316 1341 
1516 
EC I I I TM I 
1200 I I I 
sense 553-572 and antisense 1,27&l ,289) confirmed that 
these cDNA segments contaimng the EC domain were 
similar m both cell types and yielded single PCR bands 
(not shown). 
3 2 Sequences of two IFNAR deleted transcripts 
In order to determine the nucleotide sequences of the 
large and small PCR DNA products, observed by amph- 
fication of U266’ cDNA with primers 2 and 5 (Fig. 2, 
lane 3), the two DNA segments were cloned (using prim- 
PRIMERS 1 
SOLUBLE FN RECEPTOR cDNA FORM 2 
PRIMERS 1 4 5 
Fig 4 (upper) Scheme of part of transmembranal IFNAR cDNA (as m Fig l), showing the double deletion m soluble IFNAR cDNA form 2, deduced 
from sequence m Fig 5 (lower) Scheme of same region of form 2 showmg conservation of most of the IC domain (open box) The 6 residues conserved 
between the m-frame deletions are shown by single-hatched box 
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DELETION IN SOLUBLE FORM-2 OF IFNAR cDNA 
prmler 1 1290 1320 
CCA CTG ACT GTA TAT TGT GTG ?aA G‘C AGA GCA CAC ACC ATG GAT GAA AAG 
CcACT(ZxzT WATAT TOT OTGAAaGcCAGAGcACAC AcCAw.GAT car4 
P L T v Y C" K A R A H TM D E 
prxner 2a 1350 exon IX , x 1380 
CTG AAT AAA AGC AGT GTT TTT AGT GAC GCT GTA TGT GAG AAA ACA AAA CCA GGA AAT ACC 
Am OAC GCT m!A TGT GAG 
SDAVCE 
1410 1440 
TCT AAA ATT TGG CTT ATA GTT GGA ATT TGT ATT GCA TTA TTT GCT CTC KG TTT GTC ATT 
1470 1500 
TAT GCT GCG AAA GTC TTC TTG AGA TGC ATC AAT TAT GTC TTC TTT CCA TCA CTT AAA CCT 
TM 
501-2 
TM 
Sol-2 
TM 
TM 
TM 
sol-2 
TM 
SOP2 
TCT TCC AGT 
PY”” x I XT 1530 Drlmer 4 1560 
ATA GAT GAG TAT 
TAT 
TTC TCT GA?, CAG'CCA TTG AAG 
TTC TCT GAAC*G CCA Trn AaG 
AAT 
Am 
CTT 
cm 
CTG 
c!cG 
CTT TCA ACT 
CTT TCA ACT 
1590 1620 
TCT GAG GAA CAA ATC GAA AAA TGT TTC ATA ATT GAA AAT ATA AU ACA ATT GCT ACA GTA 
TCT GAG GAACAA*w! GAAAaa TOT TIC m&ATT GAAAm*mAGC ACAATT lxx ACAGTA 
SEEQIEKCFIIENISTIAT" 
Fig 5 Partial nucleotlde sequence of cloned PCR products made with primers 1 and 5a TM, sequence of large product (about 500 bp) ldentlcdl 
to transmembranal IFNAR cDNA. with codons of the TM domam doubly underhned and exons boundarles Sol-2 (bold) designates the correspond- 
mg sequence of the smaller product of about 300 bp (soluble IFNAR cDNA form 2) with deduced ammo acid sequence, interrupted by the two 
m-frame deletions 
ers 2a and 5a with EcoRI and BamHI tails, respectively) 
The sequence of resulting BlueScript plasmld DNAs with 
the larger insert of about 420 bp (Fig. 3) confirmed the 
known sequence for this region of the IFNAR cDNA, 
which contams exon IX/exon X boundaries, the TM do- 
mam m exon X and the exon X/exon XI boundary [7,13] 
In comparison, sequencing a number of plasmlds with 
the smaller product of about 260 bp, showed a deletion 
from nucleotlde 1,362 to 1,5 18 (157 bp) that removes the 
TM region (Fig 3) The identically deleted nucleotlde 
sequence was found when the correspondmg 260 bp PCR 
product from U266R cDNA (Fig 2, lane 4) was ana- 
lyzed The sequence reveals (Fig 3) that the deletion 
occurs toward the end of exon IX, which becomes pliced 
to the normal first residue of exon XI, thereby removing 
all of exon X contammg the TM segment and the begm- 
mng of the IC domain This causes a frameshift after 
codon 427 (GLU) and predicts a truncated protein end- 
mg with 7 ammo acids Asn-Ile-Ser-Leu-Asn-Ser-His (or 
S domain), not found m the transmembranal IFNAR 
(Fig 3, lower part) We designate this truncated protein, 
as soluble IFNAR form 1 
Sequencing of PCR products produced with more up- 
stream primers such as primer 1 contammg nucleotldes 
1,270-1,290 (Fig 4), revealed yet another transcript of 
the IFNAR gene Thus, PCR reactions with the primer 
pair 1 and 5a, yielded two amplified bands of about 500 
bp and 300 bp with U266’ cDNA, only the 300 bp prod- 
uct being obtained m the case of U266R (not shown) The 
sequence obtained from 10 independent plasmlds con- 
taming the smaller insert of about 300 bp, from the two 
cell types, showed two m-frame deletions of nucleotldes 
1,318 to 1,341 (m exon IX) and of nucleotldes 1,360 to 
1,518 (the end of exon IX and all of exon X), giving the 
soluble IFNAR form 2, shown m Fig 5 The 24 bp 
deletion from bases 1,318 to 1,341 explains (Fig 4) why 
this sequence was not detected, along with form 1, m the 
PCR products made with primer 2a (1,331-l ,343) Con- 
versely, we could demonstrate that the 300 bp PCR prod- 
uct of primers 1 and 5a, contained also the form 1 DNA 
because primer 2b correspondmg to nucleotldes 1,320- 
1,336 (deleted m form 2) hybridized to the 300 bp PCR 
product obtained with primers 1 and 5a pair, and al- 
lowed its secondary amphficatlon yielding the form 1 
sequence (not shown) As all the ten determined plasmld 
sequences of 300 bp products of primer 1 and 5a were 
form 2, we conclude that form 2 cDNA 1s more abundant 
than form 1 However, form 1 1s detected if one uses a 
primer (such as 2a or 2b) which dlscrlmmates between 
the two forms 
In comparison to the transmembranal IFNAR, the 
two m-frame deletions of the form 2 sequence (Fig 4) 
predict a protein m which the end of the EC domain 1s 
EC TM IC 
AA 
AA 
/ Y2 13 17, 542 ,sss,rs,o 
Fig 6 Schemes of three IFNAR cDNAs (upper) transmembranal 
form, (middle) soluble form 1. and (lower) soluble form 2 Boxes show 
EC, extracellular domam formed of two repeats [7], TM, transmem- 
brane domain. IC, mtracytoplasmatlc domain, EC’, EC”, enddeleted 
EC domains of form 1 and form 2, S, novel tad of form 1, Ic’, remaining 
IC domam of form 2 
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deleted of 8 aa followmg G1u413, conserves 6 aa (422-427 
still m exon IX) and after a further deletion of 53 aa 
(including the TM domain) contmues m the IC domain 
from Tyr4’l The IC domain of form 2 conserves 77 aa 
of the 100 aa m the transmembranal form. It is worth 
noting that the 6 aa conserved m exon IX between the 
two deletions, contam a cysteme. thereby conserving the 
8 cysteine residues found m the EC domain of the trans- 
membranal IFNAR protein 
4. Discussion 
Receptors for many cytokines exist both bound to cell 
membranes and as soluble forms comprising the ex- 
tracellular (hgand-binding) domain but truncated in a 
way which removes the transmembrane domam, thereby 
causing then release m body fluids (see [2] for review). 
For a number of receptor genes, the coexistence m the 
cells of transcripts encoding the transmembranal protem 
and of transcripts encoding corresponding soluble pro- 
teins has been shown by isolation of the respective cDNA 
forms. Transcripts for soluble receptors were identified 
for hgands such as IL-4 [ 141, IL-5 [ 151, IL-6 [6], IL-7 [ 161, 
G-CSF [17] and GM-CSF [5]. In most cases, these tran- 
scripts show a deletion of the mRNA region which en- 
codes the transmembrane domain of the receptor, the 
deletion (or an msertion for the IL-4 receptor) causmg 
a shift m the translated frame. Followmg the frameshift, 
the codons of the mtracytoplasmatic domain are no 
more translated but the sequence ncodes different ami- 
noacids (whose number can be from 4 to 150) before 
reaching a termmation codon (reviewed m [5]) The func- 
tion, if any, of the novel amino acid tail m the soluble 
receptor forms has not been established, but expression 
of such frameshifted cDNAs does produce secretion of 
the soluble receptor from the cell [5]. Formation of solu- 
ble receptor transcripts, which seems compatible with an 
alternative processmg or exon skippmg, is a process dif- 
ferent from shedding of truncated soluble receptor via 
proteolytic cleavage m which no new ammo acids are 
added, such as for soluble Type I TNF [3] and p55 IL-2 
receptors [18] The two processes may coexist, as for 
example m the case of the gp80 IL-6 receptor [4,6]. 
Soluble forms of the type I IFN receptor IFNAR of 
different sizes, have been detected in the blood and urme 
by specific antibodies and IFN-a bmdmg [8]. By PCR 
analysis of cDNAs, we show the existence of transcripts 
from the IFNAR gene which encode two different solu- 
ble receptor proteins (form 1 and form 2) which both 
lack the TM domain (Fig. 6). Compared to the trans- 
membranal cDNA sequence [7,13], form 1 has a smgle 
deletion from the end of exon IX to the normal splice 
acceptor residue of exon XI, producing a frameshift and 
a tail of 7 ammo acids. This resembles the alternative 
processing found for other cell secreted cytokme recep- 
tors [5,6]. In contrast, the more abundant form 2 has the 
unique feature to conserve most of the C-termmal part 
of the IC domain (77 aa out of 100 aa, and 3 out of the 
4 tyrosmes), despite two m-frame deletions, one m exon 
IX and one taking away the end of exon IX and all exon 
X contaming the TM domain The signalling function of 
the IC domain, which may involve tyrosme phosphoryl- 
ation [ 191, could be conserved in this second soluble IFN 
receptor form. We have observed that upon expression 
m COS-7 cells of form 2 cDNA (but not of form l), the 
protein product is detected mside the cell, in the soluble 
cytoplasm compartment (not shown). Whether form 2 
could respond to endogenously produced IFN or to m- 
ternahzed IFN, or interact wtth other cellular signalhng 
proteins remains to be investigated. Form 1, resembling 
other cell secreted soluble receptors [5] could function 
outside the cell. Both form 1 and form 2 conserve the 8 
cysteme residues of the EC domain, 4 cysteines being 
thought to be involved m folding of each of the two 
repeats characterizing the hgand-binding domain m the 
EC part of IFNAR [7] No evidence for deletions m the 
EC domain was found. Therefore, the two natural, cel- 
synthesized, soluble IFNAR forms described here 
should retam hgand-bmdmg activity, as do recombinant 
IFNAR EC domains [9] The potential function of solu- 
ble receptors as regulators of cytokme activities have 
been discussed [2], and the soluble IFNAR molecules 
could be interesting regulators for the antiviral, antipro- 
liferative or immunoregulatory functions of Type I IFN- 
a@. 
The production of the transmembranal and soluble 
IFNAR transcripts, appears to be regulated since it dif- 
fers m the two human myeloma cells studied The U266’ 
cells contam abundant ransmembranal IFNAR mRNA 
along with the form 1 and form 2 soluble IFNAR tran- 
scripts The U266R cells have lost the transmembranal 
IFNAR mRNA but clearly contam the form 1 and form 
2 mRNAs. The U266R cells lack the membranal IFNAR 
protein and show no specific cell bmdmg of exogenously 
added human IFN-a-A compared to 5,000 high affinity 
binding sites per cell for human IFN-a-A in U266’ cells 
(Lundgren E. et al., unpubhshed ata) Some molecular 
response of U266R cells to IFN can, nevertheless, till be 
detected (Abramovich et al , m preparation) The defect 
m U266R cells leading to absence of the IFNAR tran- 
scripts with all its 11 exons but allowing formation of 
alternatively processed transcripts without exon X, will 
be interesting to investigate as well as the function the 
soluble IFNAR form 1 and form 2 could play m these 
cells. 
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